Author

Ngow HA

IIUM/ UTAR/ Korea University - Cited by 16,851 - Cardiology

Biography

Ngow, Harris was born on April 15, 1974 in Malacca, Malaysia. Son of Yam Ngow and Kwee Lan Ong. Harris Ngow, Malaysian cardiologist, educator. Member Malaysian Medical Association, Kuala Lumpur, since 2001, National Cardiovasc. Disease Registry, since 2006, National Medical Research Register, since 2007, Malaysia Society Hypertension, since 2008; Member of Pharmacogenomics Association Malaysia.Assistant professor International Islamic University Malaysia, Kuantan, since 2003. Internal medicine specialist & cardiologist Hospital Tengku Ampuan Afzan, Kuantan, since 2007.
Title
Cited by
Year
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...Jama 321 (1), 69-79, 2019201
969
2019
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
CJP Schmidt AF, Carter JL, Pearce LS, Wilkins JT, Overington JP, Hingorani ADCochrane Database Syst Rev, 2020241202
241
2020
Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA
DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ...Circulation 139 (3), 351-361, 2019201
153
2019
Effect of evolocumab on coronary plaque composition
SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ...Journal of the American College of Cardiology 72 (17), 2012-2021, 2018201
98
2018
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER …
SZ Goldhaber, H Eriksson, A Kakkar, S Schellong, M Feuring, ...Vascular medicine 21 (6), 506-514, 2016201
80
2016
Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE trial
WB White, S Kupfer, F Zannad, CR Mehta, CA Wilson, L Lei, GL Bakris, ...Diabetes Care 39 (7), 1267-1273, 2016201
78
2016
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a …
J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ...Cardiovascular diabetology 17, 1-15, 2018201
75
2018
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular …
R Puri, SE Nissen, R Somaratne, L Cho, JJP Kastelein, CM Ballantyne, ...American heart journal 176, 83-92, 2016201
68
2016
Serial measurement of high-sensitivity troponin I and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE Trial (Examination of cardiovascular …
MA Cavender, WB White, P Jarolim, GL Bakris, WC Cushman, S Kupfer, ...Circulation 135 (20), 1911-1921, 2017201
68
2017
Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ...Diabetes care 42 (10), 1930-1938, 2019201
55
2019
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial
C Melloni, JH Cornel, G Hafley, ML Neely, P Clemmensen, ...European Heart Journal: Acute Cardiovascular Care 5 (6), 443-454, 2016201
53
2016
Days alive and out of hospital: exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes
AC Fanaroff, D Cyr, ML Neely, J Bakal, HD White, KAA Fox, ...Circulation: Cardiovascular Quality and Outcomes 11 (12), e004755, 2018201
49
2018
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
J Alfredsson, B Neely, ML Neely, DL Bhatt, SG Goodman, P Tricoci, ...Heart 103 (15), 1168-1176, 2017201
45
2017
Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial
V Perkovic, R Toto, ME Cooper, JFE Mann, J Rosenstock, DK McGuire, ...Diabetes Care 43 (8), 1803-1812, 2020202
44
2020
Dabigatran versus warfarin for acute venous thromboembolism in elderly or impaired renal function patients: pooled analysis of RE-COVER and RE-COVER II
SZ Goldhaber, S Schulman, H Eriksson, M Feuring, M Fraessdorf, ...Thrombosis and haemostasis 117 (11), 2045-2052, 2017201
38
2017
Serial measurement of natriuretic peptides and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE trial
P Jarolim, WB White, CP Cannon, Q Gao, DA MorrowDiabetes Care 41 (7), 1510-1515, 2018201
35
2018
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
KAA Fox, JW Eikelboom, SS Anand, DL Bhatt, J Bosch, SJ Connolly, ...European heart journal 40 (18), 1466-1471, 2019201
32
2019
Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE …
A Sharma, M Vaduganathan, JP Ferreira, Y Liu, GL Bakris, CP Cannon, ...Journal of the American Heart Association 9 (1), e012797, 2020202
32
2020
High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of …
YC Hwang, DA Morrow, CP Cannon, Y Liu, R Bergenstal, S Heller, ...Diabetes, Obesity and Metabolism 20 (3), 654-659, 2018201
31
2018
Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE trial
WB White, SR Heller, CP Cannon, H Howitt, K Khunti, RM Bergenstal, ...The American Journal of Medicine 131 (7), 813-819. e5, 2018201
28
2018

Referred From: https://scholar.google.com/citations?user=RNgBYvQAAAAJ&hl=en

Cited by
Citations 16851
h-index 38
i10-index 77
Recommended Journals
Open Access Journals